IJCM  Vol.9 No.9 , September 2018
In-Vitro Comparison of Antifungal Activity of Herbs (Darehald and Pomegranate) with Azoles
Abstract: Aim: Candida, an opportunistic organism is one of the commonest causes of hospital acquired infections among fungi. Currently available antifungal drugs have numerous adverse effects and drug-drug interactions (DDIs) along with increase in resistance over the time. Therefore, it is highly emergent to consider alternative treatments for candidal infections, having fewer adverse effects and is cost-effective. The current in-vitro study is undertaken to assess and compare the antifungal effects of the herbs, Berberis aristata (B. aristata, Darehald/Darhald) and Punica granatum (P. granatum, Pomegranate) with fluconazole and voriconazole, based on culture and sensitivity of candidal isolates. Materials and Methods: Ethanolic extracts of herbs (Berberis aristata and Punica granatum) and concentrations were formulated as per standard procedure. 130 samples were obtained for the study from in and out patients reported in clinical subsets of Ziauddin Hospital, Karachi from March to May, 2018. Samples were collected and grown according to the standard procedures like, wet mount test and gram’s staining. Species were identified by CHROM agar candida and API 20 C AUX methods. Sensitivity tests were performed by Kirby Bauer’s disc diffusion method according to CLSI guide lines M-44 A2, 2009. Data analysis was done by one-way ANOVA to compare the antifungal activities of drugs and herbs. Results: Mean inhibitory zones of herbs, B. aristata and P. granatum were highly significant against clinical candidal isolates with respective p-values of 0.00 and 0.02. Both of the herbs, B. aristata and P. granatum were found to be more sensitive, 98.5% and 97.7% respectively in comparison to fluconazole showing 42.3% and voriconazole showing 29.2% sensitivity against candidal isolates. The most resistant candidal specie was C. tropicalis that showed resistance against both fluconazole and voriconazole, contrary to that, this specie was highly sensitive to both of the herbs, showing sensitivity of 100% respective for Darehald and Pomegranate. Conclusion: In comparison to azoles: Culture sensitivity of both herbs (B. aristata and P. granatum) displayed more sensitivity against candidal isolates of patients having non-invasive and invasive candidiasis. These herbs can be considered as substitute or alternative antifungal agents to the conventional antifungal therapy, particularly in cases of treating candidemia patients, which is a life threating condition.
Cite this paper: Rizwan, R. , Shaheen, S. , Memon, Z. , Afridi, F. and Zaib, M. (2018) In-Vitro Comparison of Antifungal Activity of Herbs (Darehald and Pomegranate) with Azoles. International Journal of Clinical Medicine, 9, 703-715. doi: 10.4236/ijcm.2018.99059.

[1]   Carmona, F. and Pereira, A.M.S. (2013) Herbal Medicines: Old and New Concepts, Truths and Misunderstandings. Revista Brasileira de Farmacognosia, 23, 379-385.

[2]   Verma, S. and Singh, S. (2008) Current and Future Status of Herbal Medicines. Veterinary World, 1, 347-350.

[3]   Pal, S.K. and Shukla, Y. (2003) Herbal Medicine: Current Status and the Future. Asian Pacific Journal of Cancer Prevention, 4, 281-288.

[4]   Zafar, S., Khurram, M., Usman, R., Khan, F. and Nasim, R. (2015) Clotrimazole, Fluconazole, Ketoconazole and Itraconazole Susceptibilities of Candida Species in Vulvovaginitis. Cell, 342, Article ID: 9766463.

[5]   Nucci, M. and Lyon, S. (2014) Conference Report from the 6th Trends in Medical Mycology Meeting, Copenhagen, 11-14 October 2013: Facing the Global Threat of Fungal Disease. Current Fungal Infection Reports, 8, 116-118.

[6]   Meiller, T.F., Hube, B., Schild, L., Shirtliff, M.E., Scheper, M.A., Winkler, R. and Jabra-Rizk, M.A. (2009) A Novel Immune Evasion Strategy of Candida albicans: Proteolytic Cleavage of a Salivary Antimicrobial Peptide. PLoS ONE, 4, e5039.

[7]   Aslam, A., Akhtar, N., Hasan, F. and Shah, A.A. (2015) Prevalence and in Vitro Antifungal Susceptibility Pattern of Candida Species in a Tertiary Care Hospital, Rawalpindi, Pakistan. Pakistan Journal of Zoology, 47, 335-342.

[8]   Azie, N., Neofytos, D., Pfaller, M., Meier-Kriesche, H.-U., Quan, S.-P. and Horn, D. (2012) The PATH (Prospective Antifungal Therapy) Alliance® Registry and Invasive Fungal Infections: Update 2012. Diagnostic Microbiology and Infectious Disease, 73, 293-300.

[9]   Vengurlekar, S., Sharma, R. and Trivedi, P. (2012) Efficacy of Some Natural Compounds as Antifungal Agents. Pharmacognosy Reviews, 6, 91.

[10]   Cannon, R.D., Lamping, E., Holmes, A.R., Niimi, K., Tanabe, K., Niimi, M. and Monk, B.C. (2007) Candida albicans Drug Resistance: Another Way to Cope with Stress. Microbiology, 153, 3211-3217.

[11]   Cannon, R.D., Lamping, E., Holmes, A.R., Niimi, K., Baret, P.V., Keniya, M.V. and Monk, B.C. (2009) Efflux-Mediated Antifungal Drug Resistance. Clinical Microbiology Reviews, 22, 291-321.

[12]   Nett, J.E. and Andes, D.R. (2016) Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infectious Disease Clinics of North America, 30, 51-83.

[13]   Perlin, D.S., Shor, E. and Zhao, Y. (2015) Update on Antifungal Drug Resistance. Current Clinical Microbiology Reports, 2, 84-95.

[14]   Van der Linden, J.W.M., Arendrup, M.C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., et al. (2015) Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus. Emerging Infectious Diseases, 21, 1041.

[15]   Rathod, T., Padalia, H. and Chanda, S. (2015) The Potential of Plant Extracts against Multidrug Resistant Candida Species: A Review.

[16]   Setty, A.R. and Sigal, L.H. (2005) Herbal Medications Commonly Used in the Practice of Rheumatology: Mechanisms of Action, Efficacy, and Side Effects. Seminars in Arthritis and Rheumatism, 34, 773-784.

[17]   Vandenbossche, I., Vaneechoutte, M., Vandevenne, M., De Baere, T. and Verschraegen, G. (2002) Susceptibility Testing of Fluconazole by the NCCLS Broth Macrodilution Method, E-Test, and Disk Diffusion for Application in the Routine Laboratory. Journal of Clinical Microbiology, 40, 918-921.

[18]   McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M., Dickstein, K. and Gomez-Sanchez, M.A. (2012) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012. European Journal of Heart Failure, 14, 803-869.

[19]   Yogesh, H., Chandrashekhar, V., Katti, H., Ganapaty, S., Raghavendra, H., Gowda, G.K. and Goplakhrishna, B. (2011) Anti-Osteoporotic Activity of Aqueous Methanol Extract of Berberis aristata in Ovariectomized Rats. Journal of Ethnopharmacology, 134, 334-338.

[20]   Ng, K.P., Kuan, C.S., Kaur, H., Na, S.L., Atiya, N. and Velayuthan, R.D. (2015) Candida Species Epidemiology 2000-2013: A Laboratory-Based Report. Tropical Medicine & International Health, 20, 1447-1453.

[21]   Chandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T. and Ghannoum, M.A. (2001) Biofilm Formation by the Fungal Pathogen Candida Albicans: Development, Architecture, and Drug Resistance. Journal of Bacteriology, 183, 5385-5394.

[22]   Hirano, R., Sakamoto, Y., Kudo, K. and Ohnishi, M. (2015) Retrospective Analysis of Mortality and Candida Isolates of 75 Patients with Candidemia: A Single Hospital Experience. Infection and Drug Resistance, 8, 199-205.

[23]   Rahmani, A.H., Alsahli, M.A. and Almatroodi, S.A. (2017) Active Constituents of Pomegranates (Punica granatum) as Potential Candidates in the Management of Health through Modulation of Biological Activities. Pharmacognosy Journal, 9, 689-695.

[24]   Joshi, P.V., Shirkhedkar, A.A., Prakash, K. and Maheshwari, V.L. (2011) Antidiarrheal Activity, Chemical and Toxicity Profile of Berberis aristata. Pharmaceutical Biology, 49, 94-100.

[25]   Mazumder, P.M., Das, S. and Das, M.K. (2011) Phyto-Pharmacology of Berberis aristata DC: A Review. Journal of Drug Delivery and Therapeutics, 1, 46-50.

[26]   Di Pierro, F., Putignano, P., Villanova, N., Montesi, L., Moscatiello, S. and Marchesini, G. (2013) Preliminary Study about the Possible Glycemic Clinical Advantage in Using a Fixed Combination of Berberis aristata and Silybum marianum Standardized Extracts versus Only Berberis aristata in Patients with Type 2 Diabetes. Clinical Pharmacology: Advances and Applications, 5, 167-174.

[27]   Bassiri Jahromi, S., Pourshafie, M.R., Mirabzadeh, E., Tavasoli, A., Katiraee, F., Mostafavi, E. and Abbasian, S. (2015) Punica granatum Peel Extract Toxicity in Mice. Jundishapur Journal of Natural Pharmaceutical Products, 10, e23770.

[28]   Ali, H., Mahmood, N., Trali, G., Qamar, K. and Saga, Z. (2017) Protective Role of Pomegranate Juice and Its Peel Extract on Steroid Induced Raised Serum Creatinine in Mice. Pomegranate Juice and Serum Creatinine Level, 12, 29-34.

[29]   Uppuluri, P., Khan, A. and Edwards, J.E. (2017) Current Trends in Candidiasis Candida albicans: Cellular and Molecular Biology. Springer, Berlin, 5-23.

[30]   World Health Organization (2014) Antimicrobial Resistance: Global Report on Surveillance.

[31]   Shami, A.-M.M., Philip, K. and Muniandy, S. (2013) Synergy of Antibacterial and Antioxidant Activities from Crude Extracts and Peptides of Selected Plant Mixture. BMC Complementary and Alternative Medicine, 13, 360-375.

[32]   Kaneria, M.J. and Chanda, S.V. (2013) The Effect of Sequential Fractionation Technique on the Various Efficacies of Pomegranate (Punica granatum L.). Food Analytical Methods, 6, 164-175.

[33]   Amjad, L. and Shafighi, M. (2012) Antioxidant Activity of Leaf Different Extracts in Punica granatum. International Journal of Biological and Medical Research, 3, 2065-2067.

[34]   da Silva, A.R., de Andrade Neto, J.B., da Silva, C.R., de Sousa Campos, R., Silva, R.A.C., Freitas, D.D. and Grangeiro, T.B. (2016) Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp. Antimicrobial Agents and Chemotherapy, 60, 3551-3557.

[35]   Abduljabbar, T., Hussain, M., Adnan, T., Vohra, F. and Javed, F. (2017) Comparison of Oral Candida Species Prevalence and Carriage among Gutka-Chewers and Betel-Quid Chewers. JPMA. The Journal of the Pakistan Medical Association, 67, 350-354.

[36]   Gonçalves, B., Ferreira, C., Alves, C.T., Henriques, M., Azeredo, J. and Silva, S. (2016) Vulvovaginal Candidiasis: Epidemiology, Microbiology and Risk Factors. Critical Reviews in Microbiology, 42, 905-927.

[37]   Wayne, P.A. (2009) Clinical and Laboratory Standards Institute (CLSI) Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline. 2nd Edition, CLSI Document M44-A2.

[38]   Shino, B., Peedikayil, F.C., Jaiprakash, S.R., Ahmed Bijapur, G., Kottayi, S. and Jose, D. (2016) Comparison of Antimicrobial Activity of Chlorhexidine, Coconut Oil, Probiotics, and Ketoconazole on Candida albicans Isolated in Children with Early Childhood Caries: An in Vitro Study. Scientifica, 2016, Article ID: 7061587.

[39]   Sahoo, S., Mohanty, I., Parida, B. and Patnaik, S. (2018) Prevalence of Vulvovaginal Candidiasis in Sexually Active Females with Antifungal Susceptibility Patterns of the Isolates. International Journal of Clinical and Biomedical Research, 4, 38-41.

[40]   Espinel-Ingroff, A., Canton, E., Gibbs, D. and Wang, A. (2007) Correlation of Neo-Sensitabs Tablet Diffusion Assay Results on Three Different Agar Media with CLSI Broth Microdilution M27-A2 and Disk Diffusion M44-A Results for Testing Susceptibilities of Candida spp. and Cryptococcus Neoformans to Amphotericin B, Caspofungin, Fluconazole, Itraconazole, and Voriconazole. Journal of Clinical Microbiology, 45, 858-864.

[41]   Wayne, P. (2009) Zone Diameter Interpretive Standards, Corresponding Minimal Inhibitory Concentration (MIC) Interpretive Breakpoints, and Quality Control Limits for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. Third International Supplement CLSI Document-M444-S3, New York.

[42]   Benzie, I.F. and Wachtel-Galor, S. (2011) Herbal Medicine: Biomolecular and Clinical Aspects. Second Edition, CRC Press, Boca Raton.

[43]   Bondaryk, M., Kurzatkowski, W. and Staniszewska, M. (2013) Antifungal Agents Commonly Used in the Superficial and Mucosal Candidiasis Treatment: Mode of Action and Resistance Development. Advances in Dermatology and Allergology, 30, 293-301.

[44]   Divya, V.V. and Umamaheswari, S. (2014) Antimicrobial Activity of Selected Herbal Extracts against Multi Drug Resistant Oral Pathogens Isolated from Leprosy Patients. International Journal of Pharmaceutics, 4, 128-132.

[45]   Dhamgaye, S., Devaux, F., Vandeputte, P., Khandelwal, N.K., Sanglard, D., Mukhopadhyay, G. and Prasad, R. (2014) Molecular Mechanisms of Action of Herbal Antifungal Alkaloid Berberine, in Candida albicans. PLoS ONE, 9, e104554.

[46]   Gowhar, O., Singh, N., Sultan, S., Ain, T., Mewara, A. and Shah, I. (2015) Natural Herbs as Alternative to Synthetic Antifungal Drugs—The Future Challenging Therapy. British Biomedical Bulletin, 3, 440-452.

[47]   Anibal, P.C., Peixoto, I.T.A., Foglio, M.A. and Höfling, J.F. (2013) Antifungal Activity of the Ethanolic Extracts of Punica granatum L. and Evaluation of the Morphological and Structural Modifications of Its Compounds upon the Cells of Candida spp. Brazilian Journal of Microbiology, 44, 839-848.

[48]   Bassiri-Jahromi, S., Katiraee, F., Hajimahmoodi, M., Mostafavi, E. and Pourshafie, M.R. (2015) In Vitro Antifungal Activity of Various Persian Cultivars of Punica granatum L. Extracts against Candida Species. Jundishapur Journal of Natural Pharmaceutical Products, 10, e19754.

[49]   Pfaller, M., Diekema, D., Gibbs, D., Newell, V., Ellis, D., Tullio, V., Ling, T., et al. (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion. Journal of Clinical Microbiology, 48, 1366-1377.

[50]   Baghdadi, E., Khodavaisy, S., Rezaie, S., Abolghasem, S., Kiasat, N., Salehi, Z., Aala, F., et al. (2016) Antifungal Susceptibility Patterns of Candida Species Recovered from Endotracheal Tube in an Intensive Care Unit. Advances in Medicine.